Tysuna® Sunitinib Product Information Proprietary Name: Tysuna® Generic Name: Sunitinib Dosage Form: Hard Gelatin Capsule Strengths: 12.5 mg, 25 mg, 50 mg Indications: Gastrointestinal Stromal Tumor, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumors Download Leaflet Oncology Tysuna® Sunitinib is indicated for the treatment of gastrointestinal stromal tumor, renal cell carcinoma, and pancreatic neuroendocrine tumors.

Wellosia® Ozanimod Product Information Proprietary Name: Wellosia® Generic Name: Ozanimod Dosage Form: Capsule Strengths: 0.23 mg, 0.46 mg, 0.92 mg Indications: Multiple Sclerosis, Ulcerative Colitis Download Leaflet Other Products Wellosia® Ozanimod is indicated for the treatment of multiple sclerosis, ulcerative colitis. Product Detail: Ozanimod is a sphingosine 1-phosphate receptor modulator approved for treatment of Multiple Sclerosis (MS) and inflammatory bowel disease (IBD). Frequently asked questions: What...

Winobin® Vinorelbine Product Information Proprietary Name: Winobin® Generic Name: Vinorelbine Dosage Form: Vial and Soft Gelatine Capsule Strengths: 10 mg/1ml, 50 mg/5 ml, 20 mg, 30 mg Indications: Non-Small Cell Lung Cancer, Advanced breast cancer Download Leaflet Oncology Winobin® Vinorelbine is indicated for the treatment of non-small cell lung cancer, and advanced breast cancer.

Xantomit® Mitoxantrone Product Information Proprietary Name: Xantomit® Generic Name: Mitoxantrone Dosage Form: Vial Strengths: 20 mg/10 ml Indications: Multiple Sclerosis, Prostate Cancer, Hepatocellular Carcinoma, Breast Cancer, Non-Hodgkin’s Lymphoma, Acute Non-Lymphocytic Leukemia (ANLL) Download Leaflet Oncology Xantomit® Mitoxantrone is indicated for the treatment of multiple sclerosis, prostate cancer, hepatocellular carcinoma, breast cancer, non-hodgkin’s lymphoma, and acute non-lymphocytic leukemia (ANLL).

Xetabin® Capecitabine A smart pill, favorable tolerability and more convenient Product Information Proprietary Name: Xetabin® Generic Name: Capecitabine Dosage Form: Film-coated Tablet Strengths: 500 mg Indications: Colorectal Cancer, Breast Cancer Download Leaflet Oncology Xetabin® Capecitabine is indicated for the treatment of colorectal cancer, breast cancer.

Xybrone® Abiraterone acetate Stand up and be a real man Product Information Proprietary Name: Xybrone® Generic Name: Abiraterone Acetate Dosage Form: Film-coated Tablet Strengths: 250 mg, 500 mg Indications: Prostate Cancer Download Leaflet Oncology Xybrone® Abiraterone acetate is indicated for the treatment of prostate cancer.

Zobis® Zoledronic Acid Build it tight Product Information Proprietary Name: Zobis® Generic Name: Zoledronic Acid Dosage Form: Vial Strengths: 4 mg/5 ml Indications: Hypercalcemia of Malignancy, Multiple Myeloma, Bone Metastases from Solid Tumors Download Leaflet Oncology Zobis® Zoledronic Acid is indicated for the treatment of hypercalcemia of malignancy, multiple myeloma, and bone metastases from solid tumors.

Brescu® Abemaciclib Product Information Proprietary Name: Brescu® Generic Name: Abemaciclib Dosage Form: Film-coated Tablet Strengths: 50 mg, 150 mg Indications: Breast Cancer Download Leaflet Oncology Brescu® Abemaciclib is indicated for the treatment of patients with breast cancer.

Nibulin® Eribulin Mesylate Product Information Proprietary Name: Nibulin® Generic Name: Eribulin Mesylate Dosage Form: Vial Strengths: 1 mg/2 ml Indications: Locally Advanced or Metastatic Breast Cancer and Liposarcoma Download Leaflet Oncology Nibulin® Eribulin Mesylate is indicated for the treatment of patients with locally advanced or metastatic breast cancer and liposarcoma.